In cancer, DC predominantly play an anti-tumorigenic role through the cross-presenting of exogenous antigens via MHC class I and class II to CD8 T cells and CD4 T cells, respectively, and through the secretion of immune-stimulatory cytokines. The gene discussed is CD8A; the disease is cancer.